Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

ALN-VSP02

Alternative Names: aln-vsp02, alnvsp02, aln vsp02
Latest Update: 2012-10-12
Latest Update Note: Clinical Trial Update

Product Description

ALN-VSP02 is a RNA interference (RNAi) therapeutic comprised of lipid nanoparticle-formulated small interfering RNAs (siRNAs) targeting the expression of vascular endothelial growth factor (VEGF)-A and kinesin spindle protein (KSP). (Sourced from: https://ascopubs.org/doi/abs/10.1200/jco.2011.29.15_suppl.3025)

Mechanisms of Action: KSP Modulator,VEGF Modulator Binder

Novel Mechanism: Yes

Modality: Nucleic Acid

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Alnylam
Company Location: CAMBRIDGE MA 02142
Company CEO: Yvonne L. Greenstreet
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Oncology Solid Tumor Unspecified|Liver Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ALN-VSP02-002

P1

Completed

Liver Cancer

2012-08-01

ALN-VSP02-001

P1

Completed

Oncology Solid Tumor Unspecified

2011-07-01

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions